Reducing body myopathy - A new pathogenic FHL1 variant and literature review.
Mota IA, Correia CDC, Fontana PN, Carvalho AAS.
Neuromuscul Disord. 2021 Sep;31(9):847-853. doi: 10.1016/j.nmd.2021.03.013. Epub 2021 Apr 15.
FHL1-mutated reducing body myopathy.
Lim KY, Kim HH, Sung JJ, Oh BM, Kim K, Park SH.
Neuropathology. 2020 Apr;40(2):185-190. doi: 10.1111/neup.12619. Epub 2019 Dec 5.
Reducing body myopathy and other FHL1-related muscular disorders.
Schessl J, Feldkirchner S, Kubny C, Schoser B.
Semin Pediatr Neurol. 2011 Dec;18(4):257-63. doi: 10.1016/j.spen.2011.10.007.
Delayed onset muscle soreness : treatment strategies and performance factors.
Cheung K, Hume P, Maxwell L.
Sports Med. 2003;33(2):145-64. doi: 10.2165/00007256-200333020-00005.
[Reducing body myopathy].
Ishikawa H, Nishino I.
Ryoikibetsu Shokogun Shirizu. 2001;(35):424-6.
[Myopathy, reducing body].
Nishino I.
Ryoikibetsu Shokogun Shirizu. 2001;(34 Pt 2):255-6.
Reducing body myopathy.
Brooke MH, Neville HE.
Neurology. 1972 Aug;22(8):829-40. doi: 10.1212/wnl.22.8.829.
l-Carnitine Supplementation in Recovery after Exercise.
Fielding R, Riede L, Lugo JP, Bellamine A.
Nutrients. 2018 Mar 13;10(3):349. doi: 10.3390/nu10030349.
Muscle damage and inflammation during recovery from exercise.
Peake JM, Neubauer O, Della Gatta PA, Nosaka K.
J Appl Physiol (1985). 2017 Mar 1;122(3):559-570. doi: 10.1152/japplphysiol.00971.2016. Epub 2016 Dec 29.
Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
Latronico N, Rasulo FA, Eikermann M, Piva S.
Crit Care. 2023 Nov 13;27(1):439. doi: 10.1186/s13054-023-04676-3.
